TearLab (TEAR) Issues Earnings Results
TearLab (OTCMKTS:TEAR) (TSE:TLB) issued its quarterly earnings data on Thursday. The medical research company reported ($0.06) EPS for the quarter, Bloomberg Earnings reports. The business had revenue of $6.41 million during the quarter.
Shares of OTCMKTS TEAR opened at $0.15 on Friday. The company has a debt-to-equity ratio of -1.33, a current ratio of 1.52 and a quick ratio of 1.29. TearLab has a one year low of $0.12 and a one year high of $2.51.
Separately, ValuEngine raised TearLab from a “hold” rating to a “buy” rating in a report on Wednesday, July 4th.
TearLab Corporation operates as an in-vitro diagnostic company in the United States and internationally. It offers TearLab Osmolority System, a proprietary in vitro diagnostic tear testing platform that measures tear film osmolarity for the diagnosis of dry eye disease; and enables eye care practitioners to test for sensitive and specific biomarkers using nanoliters of tear film at the point-of-care.
Further Reading: Short Selling Stocks and Day Traders
Receive News & Ratings for TearLab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TearLab and related companies with MarketBeat.com's FREE daily email newsletter.